Abstract 471: Impact of Enrichment Strategies for Future Clinical Trials Assessing PCSK-9 Inhibitors Efficacy in Primary Prevention Settings

Publication Date

2015

Presented At:

American Heart Association Arteriosclerosis, Thrombosis and Vascular Biology/Peripheral Vascular Disease (THR Peripheral 2015 Sessions)

Content Type

Presentation

Additional Authors:

Additional authors and institutional affiliations

This document is currently not available here.

Share

COinS